Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-25-000144
Filing Date
2025-05-12
Accepted
2025-05-12 17:15:33
Documents
65
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING MARCH 31, 2025 bivi-20250331_10q.htm   iXBRL 10-Q 876131
2 EXHIBIT 31.1 bivi-20250331_10qex31z1.htm EX-31.1 12092
3 EXHIBIT 31.2 bivi-20250331_10qex31z2.htm EX-31.2 12257
4 EXHIBIT 32.1 bivi-20250331_10qex32z1.htm EX-32.1 5280
5 EXHIBIT 32.2 bivi-20250331_10qex32z2.htm EX-32.2 5130
  Complete submission text file 0001520138-25-000144.txt   4743767

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bivi-20250331.xsd EX-101.SCH 42224
7 XBRL CALCULATION FILE bivi-20250331_cal.xml EX-101.CAL 47428
8 XBRL DEFINITION FILE bivi-20250331_def.xml EX-101.DEF 138209
9 XBRL LABEL FILE bivi-20250331_lab.xml EX-101.LAB 355576
10 XBRL PRESENTATION FILE bivi-20250331_pre.xml EX-101.PRE 282169
67 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20250331_10q_htm.xml XML 622755
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 25936012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)